IRIS
PISANI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.484
EU - Europa 3.995
AS - Asia 3.092
SA - Sud America 1.717
AF - Africa 78
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.379
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.383
BR - Brasile 1.534
SG - Singapore 1.352
IE - Irlanda 959
CN - Cina 808
SE - Svezia 759
IT - Italia 481
HK - Hong Kong 437
UA - Ucraina 406
DE - Germania 378
RU - Federazione Russa 352
FI - Finlandia 197
VN - Vietnam 171
GB - Regno Unito 147
FR - Francia 97
AR - Argentina 69
IN - India 65
PL - Polonia 58
TR - Turchia 43
MX - Messico 42
IQ - Iraq 39
AT - Austria 35
CA - Canada 35
EC - Ecuador 32
NL - Olanda 30
BD - Bangladesh 28
BE - Belgio 28
UZ - Uzbekistan 23
ZA - Sudafrica 23
VE - Venezuela 19
JP - Giappone 18
MA - Marocco 18
PY - Paraguay 14
PK - Pakistan 13
CO - Colombia 12
ID - Indonesia 11
PE - Perù 11
CL - Cile 10
ES - Italia 9
IR - Iran 9
LT - Lituania 9
TN - Tunisia 9
UY - Uruguay 9
CZ - Repubblica Ceca 8
JO - Giordania 7
KZ - Kazakistan 7
OM - Oman 7
PA - Panama 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
AU - Australia 5
AZ - Azerbaigian 5
CH - Svizzera 5
EG - Egitto 5
KR - Corea 5
RS - Serbia 5
SA - Arabia Saudita 5
HN - Honduras 4
KG - Kirghizistan 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EU - Europa 3
GR - Grecia 3
RO - Romania 3
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CY - Cipro 2
GE - Georgia 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
MK - Macedonia 2
NG - Nigeria 2
NI - Nicaragua 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 14.369
Salva come PNG Salva come JPEG
Città #
Dublin 957
Jacksonville 828
Chandler 699
Singapore 595
Dallas 492
Hong Kong 437
Ashburn 404
Beijing 375
Nyköping 321
Dearborn 193
Princeton 189
Cambridge 179
Los Angeles 153
Des Moines 146
Medford 125
Ann Arbor 116
São Paulo 116
The Dalles 108
Boardman 98
Buffalo 89
Moscow 86
Ho Chi Minh City 73
New York 73
Warsaw 55
Rio de Janeiro 53
Messina 47
Wilmington 47
Woodbridge 47
Tianjin 45
Munich 44
San Mateo 40
Shenyang 40
Belo Horizonte 37
Hanoi 36
Jinan 35
Houston 32
Milan 32
Redondo Beach 30
Rome 30
Nanjing 28
Brussels 27
Curitiba 27
Vienna 24
Bremen 22
Pune 22
Salvador 22
Seattle 22
Hebei 20
Tashkent 20
Brasília 19
Campinas 19
Porto Alegre 19
Stockholm 18
Montreal 16
Norwalk 16
Zhengzhou 16
Amsterdam 15
Brooklyn 15
Ningbo 15
Chicago 14
Fortaleza 14
Guarulhos 14
Jiaxing 14
Lancaster 14
Ribeirão Preto 14
Santa Clara 14
Atlanta 13
Chennai 13
Frankfurt am Main 13
Guayaquil 13
Helsinki 13
Poplar 13
Tokyo 13
Denver 12
Fuzhou 12
Haikou 12
Hangzhou 12
Mexico City 12
Naples 12
Caruaru 11
Goiânia 11
Istanbul 11
Johannesburg 11
Manchester 11
Recife 11
London 10
Mumbai 10
Nuremberg 10
Orem 10
Phoenix 10
Santo André 10
Sorocaba 10
São José dos Campos 10
Ardabil 9
Bauru 9
Campo Grande 9
Duque de Caxias 9
Maceió 9
Quito 9
Washington 9
Totale 8.374
Salva come PNG Salva come JPEG
Nome #
" Stato confusionale di probabile natura iatrogena"; " Verosimile screzio psicotico"; " Sindrome Cefalalgica"; " Disturbo d'Ansia". Varie ipotesi ed una sola diagnosi: SENC 356
Antiepileptic drugs and MTHFR Polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients 156
"Valproic acid-amitriptyline interaction in man 154
Rischio di iperomocisteinemia in pazienti con Epilessia, portatori del diplotipo C677T/A1298C della MTHFR 143
Distribuzione di due polimorfismi genici della MTHFR in pazienti con Epilessia e correlazione con i livelli serici di omocisteina 139
ALLOPURINOL AS ADD-ON THERAPY IN REFRACTORY EPILEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY 134
ATTENTION CHARACTERIZATION IN PATIENTS WITH FRONTAL AND TEMPORAL LOBE EPILEPSY 133
FORCED NORMALISATION: OBSERVATION WITH NEW ANTIEPILEPTIC DRUGS 128
beneficial effect of donezepil in a malnourished surgical patient with severe nonalcoholic wernicke's encephalopathy 128
Aspetti neuropsichiatrici dell'epilessia 122
Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study 121
Controllo totale di crisi con l’associazione lamotrigina-gabapentin in un caso di epilessia sintomatica. 120
FORCED NORMALISATION: A RETROSPECTIVE ANALYSIS OF RISK FACTORS 119
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia 118
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 118
An epidemiological study of the clinical impact of pharmacokinetic anticonvulsant drug interactions based on serum drug level analysis 117
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 116
Differential distribution of epilepsy in patients with different types of dementia: a single-centre, retrospective study 114
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 113
A sensitive gas chromatograpic assay for the determination of serum viloxazine concetration using a nitrogen-phosphorus selective detector". Ther. Drug Monit., 6:484-488, 1984. 113
Hyperhomocysteinemia in patients with epilepsy: does it play a role in the pathogenesis of brain atrophy? A preliminary report. 112
Normalizzazione forzata e fattori di rischio: un'analisi retrospettiva 110
Effect of viloxazine on serum carbamazepine levels in epileptic patients 110
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study 110
A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats 109
Carbamazepine-viloxazine interaction in patients with epilepsy 108
CARBAMAZEPINE VALNOCTAMIDE INTERACTION IN EPILEPTIC PATIENTS - IN-VITRO IN-VIVO CORRELATION 104
Is retinal assessment useful in epileptic patients with hyperhomocysteinemia? 104
Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide 101
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 100
The contribution of inter-ictal SPECT in the evaluation of patients with epilepsy: Possible additional uses on the basis of selected cases [Il contributo della SPECT inter-critica nella valutazione del paziente con epilessia: Possibili ulteriori indicazioni sulla base di alcuni casi selezionati] 100
Repetitive transcranial magnetic stimulation induced slow wave activity modification: A possible role in disorder of consciousness differential diagnosis? 100
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 98
THE EFFECT OF COMBINING VIGABATRIN AND TIAGABINE, TWO DRUGS WITH COMPLEMENTARY GABAERGIC MECHANISMS, AGAINST NMDA-INDUCED EXCITOTOXICITY 98
Diurnal fluctuations in plasma drug levels:studies with valproic acid and carbamazepine 98
Effects of psychotropic drugs on seizure threshold 97
Prevenzione dell’epilettogenesi: revisione della letteratura, raccomandazioni terapeutiche, proposte di ricerca 97
The effect of lamotrigine on peripheral nerves. 95
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 94
Antiepileptic drug comedications in clinical practice 94
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs 94
Accidents in patients with epilepsy: types, circumstances, and complications: a European cohort study 93
Identification of amoebae in the CSF in a patient with meningoencephalitis. 93
A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide 93
Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs. 93
Meccanismi eccitotossici in un modello sperimentale in vitro: effetti della lamotrigina sul rilascio di amminoacidi eccitatori 91
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico. 90
INFLUENCE OF COMEDICATION ON THE METABOLISM OF VALPROATE 90
Differential interactions of valproic acid and valpromide with Carbamazepine in man 90
Attivita' parossistica ed agenti farmacologici: attivazione ed inibizione 90
Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. 90
Neuroprotective effects of levetiracetam against kainic acid toxicity are mediated by inhibition of lipid peroxidation 89
Prime esperienze su efficacia e tollerabilità della tiagabina in pazienti con epilessia farmacoresistente 89
Effetto della viloxazina sui livelli ematici di oxcarbazepina e dei relativi metaboliti 89
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico 87
Ruolo dei farmaci antiepilettici nella neuroprotezione da ischemia cerebrale 86
Disturbi del linguaggio e farmaci antiepilettici: analisi prospettica dei possibili fattori di rischio 85
Evaluation of Tricyclic Antidepressant Plasma Levels by an Automated Enzyme Immunoassay (EMIT) in Comparison to a High-Performance Liquid Chromatographic Method 84
ELEVATION OF PLASMA PHENYTOIN BY VILOXAZINE IN EPILEPTIC PATIENTS - A CLINICALLY SIGNIFICANT DRUG-INTERACTION 81
Il concetto di normalizzazione forzata in epilettologia 81
Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment 81
Single-dose kinetics of primidone in acute viral hepatitis 81
Crisi epilettiche indotte dall’assunzione di leflunamide in pazienti in terapia con carbamazepina 81
Specific Patient Features Affect Antiepileptic Drug Therapy Decisions: Focus on Gender, Age, and Psychiatric Comorbidities 81
Neuroprotective effect of remacemide hydrochloride against NMDA-induced excitotoxicity in isolated chick embryo retina 80
Pharmacokinetics and therapeutic plasma monitoring of antiepileptic drugs 80
COULD LAMOTRIGINE BE USEFUL IN STATUS EPILEPTICUS - A CASE- REPORT 80
EFFECTS OF THE ANTIDEPRESSANT DRUG VILOXAZINE ON OXCARBAZEPINE AND ITS HYDROXYLATED METABOLITES IN PATIENTS WITH EPILEPSY 79
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients 79
The 894G > T (Glu298Asp) variant in the endothelial NOSgene and MTHFR polymorphisms influence homocysteine levels in patients withcognitive decline. 79
Liquid chromatographic assay of lamotrigine,a new antiepileptic drug, by a hig-speed column 78
CONTRIBUTION OF INTERICTAL BRAIN PERFUSION SPECT IN ASSESSING PATIENTS WITH EPILEPSY 78
Objective cognitive dysfunction assessment in patients with subjective cognitive complaints: does it allow an early differentiation between demnetia and pseudo-dementia? 78
INTERACTION OF LAMOTRIGINE WITH SODIUM VALPROATE 76
Effects of remacemide and lamotrigine on MNDA-induced excitotoxicity in isolated chick embryo retina 76
The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction 76
Sodium valproate and valpromide:Differential interactions with carbamazepine in epileptic patients 76
Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T polymorphism in Levodopa-treated Parkinson’s disease patients 76
LAMOTRIGINE IN RESISTANT CHILDHOOD EPILEPSY 75
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 75
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration 75
Increased dipropylacetic acid bioavailability from dipropylacetamide by food 75
Valproic acid-ethosuximide interaction: A pharmacokinetic study 74
Morbidity in patients with epilepsy: type and complications: a European cohort study 73
CLINICALLY RELEVANT ANTI-EPILEPTIC DRUG-INTERACTIONS 73
Principles and current issues of antiepileptic drug therapy 73
THE INFLUENCE OF ELECTROENCEPHALOGRAPHIC FOCUS LATERALITY ON EFFICACY OF CARBAMAZEPINE IN COMPLEX PARTIAL AND SECONDARILY GENERALIZED TONIC-CLONIC SEIZURES 72
The importance of drug interactions in epilepsy therapy 72
Distribution of attention in normal people as a function of spatial location: Right-left, up-down 72
Limited place for plasma monitoring of new antiepileptic drugs in clinicalpractice. 71
LIQUID-CHROMATOGRAPHIC ANALYSIS OF ANTIEPILEPTIC DRUGS - AN OVERVIEW 71
Phenylethylmalonamide in essential tremor.A double-blind controlled study 71
Efficacia della lamotrigina nelle crisi con caduta 71
VIGABATRIN-INDUCED DECREASE IN SERUM PHENYTOIN CONCENTRATION DOES NOT INVOLVE A CHANGE IN PHENYTOIN BIOAVAILABILITY 70
Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia 70
Il contributo della SPECT inter-critica nella valutazione del paziente con epilessia:possibili ulteriori indicazioni sulla base di alcuni casi selezionati 70
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 70
Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina 69
SAFETY AND EFFICACY OF VIGABATRIN AND CARBAMAZEPINE IN NEWLY DIAGNOSED EPILEPSY:A MULTICENTER RANDOMISED DOUBLE-BLIND STUDY 68
Epilepsy Study Group of the Italian Neurological Society. Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis. 68
Totale 9.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.133
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021556 0 0 0 0 0 165 16 105 16 101 91 62
2021/20221.118 19 167 23 42 22 3 66 55 25 152 194 350
2022/20232.741 235 172 96 214 257 257 29 182 1.156 17 80 46
2023/2024637 68 122 60 69 46 130 15 26 2 29 8 62
2024/20253.325 55 45 89 154 158 75 41 962 867 151 188 540
2025/20263.309 268 615 572 764 692 398 0 0 0 0 0 0
Totale 14.476